1973•Clinical Orthopaedics and Related ResearchRequires access

Chondroblastoma of Bone A Critical Review

Andrew G. Huvos, Ralph C. Marcove

Open publisher page 150 citations

Abstract

Since the early description of “giant cell tumor variant” by Kolodny in 1927, “calcifying giant cell tumor” by Ewing in 1928, and “epiphyseal chondromatous giant cell tumor” by Codman in 1931, this tumor has been accepted and treated as a relatively rare benign neoplasm with a predilection for the epiphyscs of long bones.4, 10, 23 In 1942, Jaffe and Lichtenstein19 introduced the term “benign chondroblastoma” emphasizing this specific neoplasm to be a distinct clinicopathologic entity separate from giant cell tumor of bone. However, some of these neoplasms are still diagnosed and classified as giant cell tumors of bone, while others are misdiagnosed and regarded as chondrosarcomas or osteogenic sarcomas.38 Benign chondroblastomas of bone comprise approximately 1 per cent of benign primary bone tumors in several reported series.8, 17, 24, 28, 32, 42, 43 There are over 500 cases of chondroblastoma of bone reported in the world literature, many of which arc case reports or small series of cases.

About this research paper

What this paper is about

Since the early description of “giant cell tumor variant” by Kolodny in 1927, “calcifying giant cell tumor” by Ewing in 1928, and “epiphyseal chondromatous giant cell tumor” by Codman in 1931, this tumor has been accepted and treated as a relatively rare benign neoplasm with a predilection for the epiphyscs of long bones.4, 10, 23 In 1942, Jaffe and Lichtenstein19 introduced the term “benign chondroblastoma” emphasizing this specific neoplasm to be a distinct clinicopathologic entity separate from giant cell tumor of bone. However, some of these neoplasms are still diagnosed and classified as giant cell tumors of bone, while others are misdiagnosed and regarded as chondrosarcomas or osteogenic sarcomas.38 Benign chondroblastomas of bone comprise approximately 1 per cent of benign primary bone tumors in several reported series.8, 17, 24, 28, 32, 42, 43 There are over 500 cases of chondroblastoma of bone reported in the world literature, many of which arc case reports or small series of cases.

Why it matters

OpenAlex reports 150 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Since the early description of “giant cell tumor variant” by Kolodny in 1927, “calcifying giant cell tumor” by Ewing in 1928, and “epiphyseal chondromatous giant cell tumor” by Codman in 1931, this tumor has been accepted and treated as a relatively rare benign neoplasm with a predilection for the epiphyscs of long bones.4, 10, 23 In 1942, Jaffe and Lichtenstein19 introduced the term “benign chondroblastoma” emphasizing this specific neoplasm to be a distinct clinicopathologic entity separate from giant cell tumor of bone. However, some of these neoplasms are still diagnosed and classified as giant cell tumors of bone, while others are misdiagnosed and regarded as chondrosarcomas or osteogenic sarcomas.38 Benign chondroblastomas of bone comprise approximately 1 per cent of benign primary bone tumors in several reported series.8, 17, 24, 28, 32, 42, 43 There are over 500 cases of chondroblastoma of bone reported in the world literature, many of which arc case reports or small series of cases.

Key concepts: Chondroblastoma, Medicine, Giant-cell tumor of bone, Giant cell, Giant Cell Tumors, Pathology, Primary bone, Neoplasm

Related papers

Back to paper searchBrowse research topicsOriginal source
Chondroblastoma of Bone A Critical Review — Research Paper | ScholarLens